Genetic polymorphisms and risk of recurrent deep venous thrombosis in young people: Prospective cohort study

European Journal of Vascular and Endovascular Surgery

Volumn 30, Issue 5, 2005, Pages 545-549

  Mansilha, A ^a,b   Araujo F ^a   Severo, M ^a   Sampaio, S M ^a   Toledo, T ^a   Albuquerque, R ^a  

^a Centro Hospitalar Universitário de São João   (Portugal)

^b NONE   (Portugal)

Author keywords

Genetic polymorphism; Recurrence; Thrombophilia; Venous thrombosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DEEP VEIN THROMBOSIS; DNA DETERMINATION; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; INCIDENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; THROMBOPHILIA;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADOLESCENT; ADULT; AGE FACTORS; BLOOD COAGULATION FACTORS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MUTATION; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECURRENCE; VENOUS THROMBOSIS;

EID: 26944498631     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2005.05.038     Document Type: Article

References (21)

1. S. Schulman A.-S. Rhedin P. Lindmarker A. Carlsson G. Larfars P. Nicol et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism N Engl J Med 332 1995 1661-1665
2. British Committee for Standards in Haematology Guidelines on oral anticoagulation: 3rd edn Br J Haematol 101 1998 374-387
3. P. Prandoni A.W.A. Lensing A. Cogo S. Cuppini S. Villalta M. Carta et al. The long-term clinical course of acute deep venous thrombosis Ann Intern Med 125 1996 1-7
4. P.-O. Hansson J. Sorbo H. Eriksson Recurrent venous thromboembolism after deep vein thrombosis Arch Intern Med 160 2000 769-774
5. G. Palareti N. Leali S. Coccheri M. Poggi C. Manotti A. D'Angelo et al. Bleeding complcations of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT) Lancet 348 1996 423-428
6. C. Kearon M. Gent J. Hirsh J. Weitz M.J. Kovacs D.R. Anderson et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism N Engl J Med 340 1999 901-907
7. F.J.I. Fowkes J.F. Price F.G.R. Fowkes Incidence of diagnosed deep vein thrombosis in the general population: Systematic review Eur J Vasc Endovasc Surg 25 2003 1-5
8. British Committee for Standards in Haematology Investigation and management of heritable thrombophilia Br J Haematol 114 2001 512-528
9. P. Lindmarker S. Schulman M. Sten-Lider B. Wiman N. Egberg H. Johnsson et al. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1619A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene Thromb Haemost 81 1999 684-689
10. P.M. Ridker P. Miletich M.J. Stampfer S.Z. Goldhaber K. Lindpaintner C.H. Hennekens Factor V Leiden and risks of recurrent idiopathic venous thromboembolism Circulation 91 1995 2800-2802
11. P. Simioni P. Prandoni A.W.A. Lensing D. Manfrin D. Tormene S. Gavasso et al. The risk of recurrent venous thromboembolism in patients with an Arg506-Gln mutation in the gene for factor V N Engl J Med 336 1997 399-403
12. V. De Stefano I. Martinelli P.M. Mannucci K. Paciaroni P. Chiusolo I. Casorelli et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation N Engl J Med 341 1999 801-806
13. P. Simioni P. Prandoni A.W.A. Lensing A. Scudeller C. Sardella M.H. Prins et al. Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep vein thrombosis Blood 96 2000 3329-3333
14. P.A. Kyrle S. Eichinger The risk of recurrent venous thromboembolism VASA 31 3 2002 163-166
15. S. Eichinger A. Weltermann C. Mannhalter E. Minar C. Bialonczyk M. Hirschl et al. The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism Arch Intern Med 162 20 2002 2357-2360
16. T. Baglin R. Luddington K. Brown C. Baglin Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: Prospective cohort study Lancet 362 2003 523-526
17. P. Kyrle E. Minar C. Bialonckyk M. Hirschl A. Weltermann S. Eichinger The risk of recurrent venous thromboembolism in men and women N Engl J Med 350 2004 2558-2563
18. A. Mansilha F. Araújo M. Severo S. Sampaio T. Toledo I. Henriques et al. The association between the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor-1 gene and deep venous thrombosis in young people Phlebology 20 1 2005 48-52
19. B.J. Hunt M. Shannon D. Bevan V. Murday Is a nihlistic attitude to thrombophilia screening justified? Thromb Haemost 87 2002 918
20. T. Baglin M. Greaves Rebuttal: Is a nihilistic approach to thrombophilia screening justified Thromb Haemost 88 2002 700-701
21. G. Palareti C. Legnani B. Cosmi G. Guazzaloca C. Pancani S. Coccheri Risk of venous thromboembolism recurrence: High negative predictive value of D-dimer performed after anticoagulation is stopped Thromb Haemost 87 2002 7-12